Shareholders and Investors
Key figures 12M 2024
PREMIUMS (billion €)
+4.5%
ATTRIBUTABLE RESULT (million €)
+30.3%
ROE
10.9%
NON-LIFE COMBINED RATIO
94.4%
SOLVENCY II RATIO
202.4%*
without transitionals
*at September 2024
Take a look at all the information in our Equity Story.
